Valeant Pharmaceuticals To Webcast 2012 Annual Meeting Of Shareholders

April 30, 2012

MONTREAL, April 30, 2012 /PRNewswire via COMTEX/ --Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it will conduct a live webcast of the company's annual meeting of shareholders. The meeting will be held on Wednesday, May 30, 2012, at 9:00 a.m. ET at Laboratoire Dr Renaud, 2805 Louis-R. Renaud Square, Laval, Quebec H7V 0A3, Canada. Only shareholders of record at the close of business on the record date will be entitled to vote at the meeting and any adjournments or postponements thereof.

A live webcast and audio archive of the presentation will be available on the company's Web site at www.valeant.com. Click on Investor Relations, and then the link to Events and Presentations. Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast.

About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics. More information about Valeant can be found at www.valeant.com.

(Logo: http://photos.prnewswire.com/prnh/20101025/LA87217LOGO)

Contact Information:
Laurie W. Little
949-461-6002
laurie.little@valeant.com